Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
Papillary Thyroid Carcinoma | Papillary Thyroid Cancer | Papillary Microcarcinoma of the ThyroidThis is a prospective, observational, multi-center study examining the long-term outcomes of patients with small, low risk papillary thyroid cancer who offered the choice of active surveillance (close follow-up to monitor for potential disease progression) or immediate surgery.
null
Conditions de participation
-
Sexe:
ALL -
Âges admissibles:
18 and up
Critères de participation
Inclusion Criteria:
* Patients 18 years of age or older.
* Newly diagnosed previously surgically untreated papillary thyroid cancer (PTC) or suspicious for PTC on fine needle aspiration biopsy of the thyroid. PTC must be \< 2 cm in maximal diameter on thyroid ultrasound.
* The absence of metastatic cervical lymphadenopathy or gross extrathyroidal extension of PTC, as confirmed on neck ultrasound imaging.
* The absence of other current absolute indication for thyroid or parathyroid surgery (e.g. severe hyperthyroidism that cannot be controlled medically, large goitre with severe compressive symptoms, or primary hyperthyroidism meeting surgical criteria).
Exclusion Criteria:
* Metastatic thyroid cancer (lymph nodes or distant).
* History of prior thyroid surgery for any indication.
* The primary PTC being on the trachea or immediately adjacent to the recurrent laryngeal nerve, and with progression would be deemed to be at high risk of growth into these critical structures.
* Clinical signs, imaging, or laryngoscopy findings suggestive of locally advanced thyroid cancer (i.e. vocal cord paralysis due to the thyroid cancer or any clinical or radiographic signs of extrathyroidal invasion into adjacent structures such as the strap muscles of the neck, trachea or esophagus).
* Known/suspected poorly differentiated or non-papillary thyroid cancer.
* Medically unfit for surgery due to severe co-morbidity. Severe comorbidity may include another active malignancy with limited life expectancy of \< 1 year).
* Pregnancy at the time of study enrollment.
* Unable/unwilling to provide informed consent for the study or comply with study follow-up procedures due to current active physical limitations/medical co-morbidity, cognitive, or psychiatric impairment substance abuse, or other reasons.
Lieu de l'étude
St. Joseph's Healthcare
St. Joseph's HealthcareHamilton, Ontario
Canada
Contactez l'équipe d'étude
Han Zhang
CHU de Québec - Université Laval
CHU de Québec - Université LavalQuébec, Quebec
Canada
Contactez l'équipe d'étude
Maryse Brassard, MD
Nathalie Audet, MD
Nova Scotia Health
Nova Scotia HealthHalifax, Nova Scotia
Canada
Contactez l'équipe d'étude
Martin Corsten, MD
Martin Corsten
(902) 473-4420Division chirurgie ORL et cervico-faciale
Division chirurgie ORL et cervico-facialeMontreal, Quebec
Canada
Contactez l'équipe d'étude
Eric Bissada
Hortensia Mircescu
University of Calgary, Cumming School of Medicine
University of Calgary, Cumming School of MedicineCalgary, Alberta
Canada
Contactez l'équipe d'étude
Shamir Chandarana
Sana Ghaznavi
Lawson Health Research Institute
Lawson Health Research InstituteLondon, Ontario
Canada
Contactez l'équipe d'étude
Deric Morrison, MD
Adrian Mendez, MD, PhD
University of British Columbia
University of British ColumbiaVancouver, British Columbia
Canada
Contactez l'équipe d'étude
Eitan Prisman
University Health Network
University Health NetworkToronto, Ontario
Canada
Contactez l'équipe d'étude
Anna M Sawka, MD, PhD
David P Goldstein, MD, MSc
- Étude parrainée par
- University Health Network, Toronto
- Participants recherchés
- Plus d'informations
- ID de l'étude:
NCT04624477